Global Fund Funding Allocation

The Global Fund is a worldwide partnership to defeat HIV, tuberculosis (TB) and malaria and ensure a healthier, safer and more equitable future for all. We raise and invest more than US$5 billion a year to fight deadly infectious diseases, challenge the injustice that fuels them, and strengthen health systems and pandemic preparedness in more than 100 of the hardest hit countries. The Global Fund provides 62% of all international financing for malaria programs and has invested more than US$19.1 billion in malaria control programs as of June 2024. [1]  

The Global Fund raises and invests money in three-year cycles known as Replenishments.  The first of these meetings, the preparatory meeting, is where Global Fund partners and potential donors are given an update on progress in the fight against HIV, TB and malaria, along with a detailed strategic plan for future programs and their financial need. This investment case details how the requested financing will translate into desired goals: lives saved, infections averted, and even long-term economic gains achieved by reducing global disease burden. MAPs statistical modelling expertise is essential to evaluate impact of malaria control measures 

In 2024 MAP provide crucial analysis estimating the impact on malaria morbidity and mortality of potential changes to Global Fund (GFATM) disease split. Advocacy efforts using these estimates resulted in the GFATM Board voting to revise the split [2], meaning an additional $491M USD in funding for malaria in the event of a status quo replenishment for the 8th replenishment. Outputs from this work were also shared in an RBM press release [3], quoted at the 79th UN General Assembly [4], and featured in the 2024 African Union Malaria Progress Report [5].